Which statement best describes the effect of starting an alpha-blocking agent such as tamsulosin during catheterization for acute urinary retention?

Which statement best describes the effect of starting an alpha-blocking agent such as tamsulosin during catheterization for acute urinary retention?

• A. Nearly doubles the success rate
• B. Has no effect
• C. Guarantees voiding
• D. Decreases the success rate

Answer: (A)

Starting an alpha-blocking medication during catheterization for acute urinary retention works by relaxing the smooth muscle in the bladder neck and prostatic urethra. This reduces dynamic obstruction and lowers outlet resistance, making it much easier for the bladder to empty once the catheter is removed. In men with benign prostatic hyperplasia who are in retention, this relaxation translates into a higher chance of successful spontaneous voiding after catheter removal, with studies showing a substantial improvement—often described as about a twofold increase over not using an alpha-blocker. This does not guarantee voiding, and there are potential risks to consider, such as dizziness or orthostatic hypotension, especially in older patients. So the best description is that starting tamsulosin during catheterization nearly doubles the likelihood of success in the subsequent voiding trial, reflecting the meaningful pharmacologic benefit seen in practice.

Starting an alpha-blocking medication during catheterization for acute urinary retention works by relaxing the smooth muscle in the bladder neck and prostatic urethra. This reduces dynamic obstruction and lowers outlet resistance, making it much easier for the bladder to empty once the catheter is removed. In men with benign prostatic hyperplasia who are in retention, this relaxation translates into a higher chance of successful spontaneous voiding after catheter removal, with studies showing a substantial improvement—often described as about a twofold increase over not using an alpha-blocker.

This does not guarantee voiding, and there are potential risks to consider, such as dizziness or orthostatic hypotension, especially in older patients. So the best description is that starting tamsulosin during catheterization nearly doubles the likelihood of success in the subsequent voiding trial, reflecting the meaningful pharmacologic benefit seen in practice.